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The Arterial Pole of the Mouse Heart
Forms from Fgf10-Expressing Cells
in Pharyngeal Mesoderm
chick heart, appearing substantially after looping (de la
Cruz et al., 1977).
Despite the fact that OFT development and septation
are critical steps in the establishment of the circulatory
system, the origins of OFT myocardial precursor cells
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75724 Paris Cedex 15 and the processes involved in extension of the arterial
pole of the heart remain unknown. Here, we analyze aFrance
2 Department of Anatomy transgenic mouse line in which -galactosidase activity,
due to a position effect, is observed at E9.5 in the rightand Developmental Biology
St. George’s Hospital Medical School ventricle, OFT, and splanchnic and pharyngeal meso-
derm contiguous to OFT myocardium. This transgeneLondon SW17 0RE
United Kingdom has integrated upstream of the fibroblast growth factor
10 gene (Fgf10), and the expression pattern of Fgf10 in
pharyngeal mesoderm indicates that the nlacZ trans-
gene is under transcriptional control of Fgf10 regulatory
Summary
sequences. Comparison of Fgf10 and transgene expres-
sion patterns, together with DiI labeling of cultured
Development of the arterial pole of the heart is a critical
mouse embryos, suggests that there is a continuous
step in cardiogenesis, yet its embryological origin re-
movement of myocardial precursor cells from the pha-
mains obscure. We have analyzed a transgenic mouse
ryngeal mesoderm into the arterial pole of the heart
line in which -galactosidase activity is observed in
during OFT morphogenesis.
the embryonic right ventricle and outflow tract of the
heart and in contiguous splanchnic and pharyngeal
Resultsmesoderm. The nlacZ transgene has integrated up-
stream of the fibroblast growth factor 10 (Fgf10) gene
The pattern of -galactosidase activity in the Mlc1v-and comparison with the expression pattern of Fgf10
nlacZ-24 transgenic mouse line is presented in Figurein pharyngeal mesoderm indicates transgene control
1. At E9.5, -galactosidase activity is observed in theby Fgf10 regulatory sequences. DiI labeling shows a
myocardium of the OFT and embryonic right ventricleprogressive movement of cells from the pharyngeal
(Figures 1A, 1B, 1D, and 1E). Transgene expression isarch region into the growing heart tube between em-
also observed in the pharyngeal region, including thebryonic days 8.25 and 10.5. These data suggest that
mesodermal core of the branchial arches and thearterial pole myocardium originates outside the classi-
splanchnic epithelial dorsal wall of the pericardial cavity.cal heart field.
This extracardiac expression domain is contiguous to
OFT myocardial cells across the mesothelial wall of the
Introduction aortic sac (Figures 1B and 1E). Genes encoding cardiac
differentiation markers, including -cardiac actin, are
Vertebrate heart development initiates with the migra- expressed in OFT myocardium but not in the dorsal
tion of cardiac precursors to the anterior lateral region pericardial wall or branchial arch mesoderm (Figure 1C).
of the embryo and the differentiation of cardiomyocytes Other sites of transgene expression include endothelial
within splanchnic mesoderm (see Fishman and Chien, cells in the distal OFT and arch arteries, the developing
1997). Morphogenesis of the splanchnic epithelium at thyroid, limb bud mesenchyme, the posterior pituitary,
the time of foregut invagination generates a heart tube and mesenchymal cells associated with endodermal
with a caudal venous pole and rostral arterial pole. As derivatives including the lung, stomach, and pancreas
the heart tube closes dorsally, the ventricular region (Figure 1).
loops to the right and the venous pole is displaced ros- The extracardiac domain of transgene expression
trally behind the ventricles. During this process, the contiguous to the distal end of the OFT is highly dynamic
heart tube grows in length extremely rapidly (over 4-fold between E8.5 and E10.5. This is illustrated in ventral
between embryonic days [E] 8 and 9 in the mouse) views of embryos with the heart removed at E8.5, 9.5,
through the addition of extracardiac cells to the poles. At and 10.5 (Figures 1G–I). At E8.5, transgene activity is
the arterial pole of the mouse heart, splanchnic epithelial observed in a population of cells in the dorsal wall of
cells continue to transform into cardiomyocytes during the pericardial cavity and pharyngeal region, which sur-
E9 to give rise to the distal outflow tract (OFT; Viragh round the arterial pole of the heart (Figure 1G). By E9.5,
and Challice, 1973). BMPs, which promote cardiomyo- bilaterally paired streams of -galactosidase-positive
genesis (Schultheiss et al., 1997), are expressed in arte- cells are observed in the pharyngeal region, including
rial pole myocardium at this stage (Jones et al., 1991). cells in the dorsal wall of the pericardial cavity (Figure
The distal OFT is also a late-added component of the 1H). By E10.5, almost no expression is observed in the
dorsal pericardial wall adjacent to the OFT, whereas
the myocardial wall of the arterial pole of the heart is3 Correspondence: rkelly@pasteur.fr (R.G.K.), margab@pasteur.fr
(M.E.B.) -galactosidase positive (Figure 1I). A boundary of
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transgene expression is observed at the distal end of
the OFT at E11.5 (Figure 1F); at this stage, the transfor-
mation of epithelial cells into cardiac muscle, as moni-
tored by electron microscopy, is complete (Viragh and
Challice, 1973).
The Mlc1v-nlacZ transgene contains a truncated
mouse Mlc1v/s myosin light chain promoter upstream
of nlacZ. Since the expression pattern of line 24 is spe-
cific to one out of four independent founder mice and
endogenous Mlc1v transcription at E8 and E9.5 is only
observed in the myocardium (Lyons et al., 1990), trans-
gene expression is likely to result from a position effect
due to regulatory elements at the site of transgene inte-
gration; it remains possible, however, that sequences
in the Mlc1v promoter contribute to myocardial expres-
sion. DNA flanking the integration site was isolated using
inverse PCR in order to identify candidate genes for
the endogenous target of these regulatory elements. A
transgene-genomic junction fragment was cloned con-
taining 1.6 kb of genomic DNA sequence adjacent to
the integration site. Six hundred bp of unique sequence
within this region is homologous to a human DNA se-
quence contained on a 190 kb BAC (GenBank accession
number AC022990) which maps to chromosome 5. The
only known gene on this BAC encodes a member of the
fibroblast growth factor family of signaling molecules,
FGF10. A PAC clone containing the 5 exon of mouse
Fgf10 (Crackower et al., 1998) also contains the trans-
gene flanking sequence 114 kb 5 to the ATG of Fgf10
(Figure 1J). Thus, both human and mouse homologs of
Figure 1. -Galactosidase Activity of the Mlc1v-nlacZ-24 the flanking sequence lie upstream of the Fgf10 gene,
Transgene
which is a candidate target of the regulatory elements
(A and B) Left lateral views. X-gal incubation at E9.5 reveals -gal- trapped by the Mlc1v-nlacZ-24 transgene.
positive cells in pharyngeal mesoderm of all branchial arches (black
Fibroblast growth factors are intercellular signalingarrows), OFT myocardium (oft), limb bud mesenchyme (lb), the de-
molecules which function by the activation of transmem-veloping posterior pituitary (p), nasal placodes (n), first branchial
brane tyrosine kinase receptors and play multiple keyarch ectoderm (black arrowhead), and lung bud mesenchyme (l).
Scattered -gal-positive cells (white arrowhead) are observed in the roles in vertebrate embryonic development. During heart
left ventricle (lv). la, left atrium. development, FGFs expressed in foregut endoderm and
(C) -cardiac actin transcripts accumulate throughout the heart at precardiac mesoderm have been implicated in cardio-
E9.5. myocyte specification and differentiation (see Lough(D) Sagittal section showing -gal activity in the dorsal wall of the
and Sugi, 2000). Fgf10 has been reported to be ex-pericardial cavity (black arrowhead) contiguous to the sixth
pressed in the adult heart by Northern blot hybridizationbranchial arch mesoderm (black arrow), the mesodermal core of
(Tagashira et al., 1997) and RNase protection analysisanterior arches (open arrowheads), and first branchial arch ecto-
derm (white arrowhead). (Beer et al., 1997). We investigated whether Fgf10 was
(E) Transverse section showing the continuity of -gal activity from expressed in the heart and pharyngeal region at early
the dorsal wall of the pericardial cavity (black arrowheads) across stages of mouse development using whole-mount in
the aortic sac (open arrowhead) into the myocardial wall of the OFT
situ hybridization. Fgf10 expression was compared withand embryonic right ventricle (rv). -Gal activity is also detected
the profile of -galactosidase activity of the Mlc1v-in branchial arch mesoderm (black arrow), endothelial cells of the
nlacZ-24 transgene and the distribution of nlacZ tran-branchial arch arteries (white arrowhead), and the developing thy-
scripts in transgenic embryos.roid (t) as, aortic sac.
(F) At E11.5, a boundary of transgene expression is observed at the At E7.5, -galactosidase activity (Figure 2A) accumu-
distal end of the OFT (arrow). lates in anterior mesoderm medially to the earliest differ-
(G–I) Ventral views of Mlc1v-nlacZ-24 embryos with the heart re- entiating cardiomyocytes marked by -cardiac actin
moved, showing -gal-positive cells in the dorsal wall of the pericar-
expression (Figure 2E). Fgf10 transcripts are also ex-dial cavity (arrows) and branchial arches (arrowheads) at E8.5 (G) and
pressed in this mesodermal region (Figure 2C), in aE9.5 (H). At E10.5 (I), few -gal-positive cells (arrows) are observed in
highly similar profile to nlacZ transcripts in transgenicthe dorsal pericardial wall. The scale bars in (D) and (E) represent
100 m. embryos (Figure 2B). An additional caudal domain of
(J) Structure of mouse PAC clone RPCI21 644L10 showing the posi- endogenous Fgf10 expression was observed which is
tion of the transgene flanking sequence (gray box) relative to the 5 not a site of Mlc1v-nlacZ-24 transgene expression (Fig-
exon of Fgf10 (black box). Arrows indicate the site of integration of ure 2C, arrows). Transcripts of another FGF gene, Fgf8,
the Mlc1v-nlacZ-24 transgene and the direction of Fgf10 transcrip-
also accumulate in the region where the Mlc1v-nlacZ-24tion. P, PI-SceI; K, KpnI; SII, SacII.
transgene is expressed (Figure 2D; Crossley and Martin,
1995). As the heart tube forms at E8, -galactosidase
activity is observed in a ring at the arterial pole of the
Origin of Arterial Pole Myocardium
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Figure 2. The Expression Pattern of the
Mlc1v-nlacZ-24 Transgene and Fgf10 from
E7.5 to E8.5
(A–E) E7.5, ventral views; X-gal incubation (A);
whole-mount in situ hybridization (B–E).
(A) -gal-positive cells are observed medial
to the cardiac crescent.
(B–D) nlacZ transcripts in transgenic embryos
are observed in a region medial and caudal
to the cardiac crescent. Fgf10 (C) and Fgf8
(D) are also expressed in this region; an addi-
tional caudal domain of Fgf10 expression is
observed (arrows).
(E) -cardiac actin transcripts mark cardio-
myocytes within the cardiac crescent.
(F) At E8, -gal-positive cells are observed at
the arterial pole of the heart (arrow) and dorsal
to the heart tube (arrowheads).
(G and H) nlacZ (G) and Fgf10 (H) transcripts
are observed dorsal to the heart tube (arrow-
heads).
(I) A transverse section at E8.25 reveals -gal-
positive cells in splanchnic epithelium (black
arrowheads) contiguous to anterior mesen-
chyme (arrows) and adjacent to foregut endo-
derm (fg), and in somatic mesoderm (white
arrowheads). ht, heart tube; dm, dorsal meso-
cardium.
(J) Fgf10 transcripts are observed in anterior mesenchyme (arrows) and splanchnic epithelium (arrowheads).
(K) Left lateral view at E8.5 showing -gal activity in the arterial pole of the heart and pharyngeal mesoderm (arrows); lv, left ventricle.
(L) High-level nlacZ transcript accumulation is observed in pharyngeal mesoderm (arrows).
(M) Fgf10 transcripts are detected in pharyngeal mesoderm (arrows), most strongly in the region of the sixth arch (black arrow).
(N) Transverse section showing nlacZ transcripts in pharyngeal, splanchnic (black arrowheads), and somatic mesoderm (white arrowheads),
but not in the heart tube (ht). fg, foregut.
(O) Fgf10 transcripts accumulate in pharyngeal (arrows), somatic, and splanchnic mesoderm (arrowheads). The scale bars represent 50 m.
(P) Cartoon showing the pattern of -gal activity of the Mlc1v-nlacZ-24 transgene during heart tube formation and looping. Dark gray, -gal-
positive cells; hatched, cardiac crescent. Inset: transverse sections at the linear heart tube stage (a) and through the looping heart (b).
heart which is continuous with two domains of expres- During heart tube formation and foregut invagination,
these -galactosidase-positive cells become displacedsion dorsal to the heart tube (Figure 2F, arrowheads).
A transverse section (Figure 2I) shows that the latter anteriorly and dorsally relative to the heart tube. Rupture
of the dorsal mesocardium and morphogenesis of the-galactosidase-positive cells are in the medial splanch-
nic epithelium comprising the dorsal wall of the pericar- pharyngeal region results in the isolation of -galactosi-
dase-positive cells in the dorsal pericardial wall behinddial cavity. These cells are contiguous to -galactosi-
dase-positive mesenchymal cells in anterior mesoderm the looping heart tube and the restriction of transgene-
expressing cells to branchial arch mesoderm converg-and -galactosidase-negative myocardial cells within
the heart tube; the boundary between transgene- ing on the arterial pole of the heart.
By E9.5, -galactosidase activity is observed in theexpressing splanchnic mesoderm and nonexpressing
myocardial cells is the dorsal mesocardium. At this myocardial wall of the OFT and embryonic right ventri-
cle, and in a contiguous extracardiac population of pha-stage, the distribution of nlacZ transcripts is comparable
to that of -galactosidase activity dorsal to the heart ryngeal mesodermal cells (Figures 1B and 3C). The dis-
tribution of Fgf10 in the mesodermal core of thetube (Figure 2G); this profile is similar to that of Fgf10,
which is expressed in anterior mesenchyme and branchial arches and dorsal pericardial wall at this stage
is highly comparable to that of nlacZ in Mlc1v-nlacZ-24splanchnic epithelium but does not extend as far as the
dorsal mesocardium (Figures 2H and 2J). embryos (Figures 3A and 3B). Both transcripts are also
observed in the outer curvature of the embryonic rightAt E8.5, -galactosidase activity is observed in the
arterial pole of the heart and pharyngeal mesoderm (Fig- ventricle (Figures 3A and 3B). Fgf10 is also expressed
at a number of other sites of Mlc1v-nlacZ-24 transgeneure 2K). nlacZ transcripts accumulate predominantly in
pharyngeal mesoderm (Figure 2L); Fgf10 transcripts are activity (Figure 3D; compare with Figure 1A). Fgf10 tran-
scripts do not accumulate in the myocardial wall of thealso expressed in this region, at a lower level, and are
more abundant in mesoderm of the caudal branchial OFT (Figures 3E, 3I, and 3M). Strikingly, nlacZ transcripts
are also not observed in the distal OFT, but accumulatearches (Figure 2M). Both nlacZ and Fgf10 transcripts
are observed in splanchnic and somatic mesoderm, in in branchial arch mesoderm and the dorsal pericardial
wall (Figures 3F, 3J, and 3N). In contrast, -cardiac actinaddition to pharyngeal mesenchymal cells (Figures 2N
and 2O). In summary, the Mlc1v-nlacZ-24 transgene is is expressed in OFT myocardium, but not the dorsal
pericardial wall or pharyngeal mesoderm (Figures 3Hexpressed in a bilateral population of Fgf10-expressing
cells located medial to the cardiac crescent (Figure 2P). and 3L). The lack of nlacZ transcripts in the distal OFT
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Figure 3. Comparison of Fgf10 and nlacZ
Transcripts with -Galactosidase Activity at
E9.5
(A) Right lateral view showing Fgf10 tran-
scripts in the mesodermal core of the
branchial arches (arrows) and right ventricle
(rv).
(B) nlacZ transcripts are observed in pharyn-
geal mesoderm (arrows) and the outer curva-
ture of the embryonic right ventricle of Mlc1v-
nlacZ-24 embryos.
(C) -Gal activity is observed in the right ven-
tricle (rv) and OFT myocardium contiguous
to positive cells in the dorsal pericardial wall
(arrowhead) and pharyngeal region (arrows).
(D) Fgf10 is also expressed in limb bud
mesenchyme (lb), nasal placodes (n), first
branchial arch ectoderm (black arrowhead),
and lung bud mesenchyme (l).
(E–H) Ventral views of E9.5 embryos with the
hearts removed showing Fgf10 transcripts (E)
in the caudal region of the dorsal pericardial
wall (black arrowheads), but not in OFT myo-
cardium (white arrowhead) or adjacent epi-
thelial cells (arrow). This expression profile
is similar to that of nlacZ transcripts (F) but
different from the distribution of -gal-posi-
tive cells (G). -cardiac actin transcripts ac-
cumulate in OFT myocardium (white arrow-
head) but not the dorsal pericardial wall
(arrow) (H).
(I–L) Transverse sections showing Fgf10 (I) and nlacZ (J) transcripts and -gal-positive cells (K) in the embryonic right ventricle (rv) and dorsal
wall of the pericardial cavity (arrowheads). -cardiac actin transcripts are detected throughout the myocardium (L). lv, left ventricle.
(M–O) Transverse sections at the level of the OFT showing that Fgf10 (M) and nlacZ (N) transcripts are not detected in the myocardial wall
of the distal OFT (black arrow), whereas -gal activity (O) is observed in the OFT myocardial wall and aortic sac mesothelium (arrowheads);
Fgf10 and nlacZ transcripts and -gal activity colocalize in pharyngeal mesoderm (white arrows). The scale bars represent 100 m.
(P) Cartoon showing Fgf10 expression in anterior mesenchyme in relation to the developing OFT. ec, ectoderm; en, endoderm; sm, splanchnic
mesoderm; pc, pericardial cavity; nt, neural tube; a, dorsal aorta; fg, foregut.
of Mlc1v-nlacZ-24 embryos at E9.5 diverges from the 4E–4H). These results suggest that there is a continuous
movement of cells from the pharyngeal region into theprofile of -galactosidase activity at the same stage
(Figures 3G, 3K, and 3O). These data suggest that arterial pole of the heart between E8.25 and E10.5.
-galactosidase activity in the myocardial wall of the
OFT and adjacent dorsal pericardial wall reflects accu- Discussion
mulated protein in cells which have downregulated
transgene transcription, probably reflecting the different The Mlc1v-nlacZ-24 transgene has integrated 114 kb
upstream of Fgf10 and is expressed in a highly similarhalf-lives of -galactosidase and nlacZ or Fgf10 mRNA.
-galactosidase activity may thus provide a pulse-chase pattern to that of Fgf10 at multiple sites in the embryo,
thus behaving like an Fgf10 enhancer trap. Sites ofreadout of transgene transcriptional activity in pharyn-
geal mesoderm. These observations raise the possibility -galactosidase activity but not Fgf10 or nlacZ tran-
script accumulation may be due to differential -galac-that a subset of Fgf10-expressing cells in pharyngeal
mesoderm move from the branchial arch region toward tosidase and mRNA stability, providing a pulse-chase
readout of Fgf10 transcription. A similar divergence be-the heart to differentiate as cardiomyocytes, concomi-
tant with the downregulation of Fgf10 transcription and tween transcript and protein distribution has been ob-
served for transgenes expressed in the somite (Hadchouelthe rapid elongation of the arterial pole that occurs be-
tween E8.5 and E10.5 (Figure 3P). et al., 2000). Our observations suggest that -galactosi-
dase-positive cells in the distal OFT have downregulatedWe investigated whether myocardial precursor cells
from the branchial arch region move into the growing transcription of the transgene, reflecting the downregu-
lation of Fgf10, and have moved into this position fromarterial pole of the heart during E8 and E9 using DiI
labeling. Two series of experiments were carried out pharyngeal mesoderm where high-level transcription
and -galactosidase activity colocalize. Mesenchymalinvolving labeling of extracardiac cells in the pharyngeal
region at E8.25 and E9.5, followed in each case by em- cells in the pharyngeal region are continuous laterally
with the splanchnic and somatic mesodermal layersbryo culture for 24 hr. When mesodermal cells dorsal
to the heart were labeled at E8.25 by injection through flanking the coelomic cavity and provide a potential
source of precursor cells for the splanchnic mesodermthe foregut endoderm, DiI-labeled cells were observed
in the proximal OFT after 24 hr (Figures 4A–4D). When and early heart tube (De Ruiter et al., 1992). Our data
suggest that this process continues throughout E8 andcells in the second branchial arch were labeled at E9.5,
DiI was observed in the distal OFT after 24 hr (Figures E9 to provide precursor cells for the arterial pole of the
Origin of Arterial Pole Myocardium
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2000). Finally, within the heart, neural crest cells give
rise to the aorticopulmonary septum rather than the
myocardial wall of the OFT (Epstein et al., 2000; Waldo
and Kirby, 1999). Despite these basic differences, distal
OFT myocardial precursor cells and cardiac neural crest
cells are closely apposed in the pharyngeal region be-
tween E9.5 and E10.5, and the contribution of these two
cell populations to the heart may be coordinated at later
stages of OFT development.
Fgf10-expressing cells are positioned medially to the
Figure 4. DiI Labeling of Anterior Mesoderm during OFT Elongation early myocardium, suggesting that regionalization of the
(A–D) Labeling at E8.25. embryonic heart along the venous-arterial axis results
(A) Video still immediately after DiI label was introduced into meso-
in part from medial-lateral patterning of cardiac precur-dermal cells dorsal to the linear heart tube at E8.25 through the
sors. Zebrafish ventricular precursors lie medial to atrialanterior intestinal portal (arrow, DiI spot).
precursors within the precardiac mesoderm and are the(B and C) Ventral (B) and lateral (C) views of the embryo shown in
(A) after 24 hr of embryo culture, showing DiI label in the proximal first cells to form the early heart tube (Yelon et al., 1999);
OFT (arrows). Note the DiI-labeled cells in foregut endoderm, which these cells express Fgf8, which is required for the earli-
probably correspond to the site of injection (arrowheads). est stages of cardiogenesis, including the induction of
(D) An additional example shows DiI-labeled cells in the proximal
Gata4 and Nkx2.5 transcription (Reifers et al., 2000). InOFT.
Xenopus, mesoderm medial to that which forms the(E–H) Labeling at E9.5. Embryo immediately after DiI label was intro-
early heart tube expresses Nkx2.5 but not downstreamduced into the second branchial arch through the yolk sac ([E],
arrow, DiI spot). cardiac markers (Raffin et al., 2000). While these Nkx2.5-
(F–H) Examples of hearts after 24 hr of embryo culture showing DiI- expressing cells are fated to become the dorsal pericar-
labeled cells in the distal OFT and aortic sac mesothelium (arrows). dial wall and dorsal mesocardium at the linear heart
In (F) and (G), a trail of DiI label from the most ventrally labeled cells
tube stage, our observations suggest that they may con-back toward the branchial arch region can be observed (arrow-
tribute to the OFT at later developmental stages.heads).
FGF signaling plays a major role in controlling cell
migration including, in Drosophila, the directed migra-
tion of mesodermal cells to the site at which cardiomyo-heart. In support of this, DiI labeling shows that there is
genesis is activated, a process dependent on the FGFa progressive movement of cells from distal pharyngeal
receptor Heartless (see Skaer, 1997). Fgf10 has beenmesoderm into the growing arterial pole of the heart
shown to control the directed movement and prolifera-during E8 and E9. In addition to the OFT, -galactosi-
tion of epithelia through interactions with other signalingdase activity is observed in the embryonic right ventricle,
molecules including BMPs and Shh (see Hogan, 1999),suggesting that the interventricular region is the leading
and to be involved in the maintenance of stem cell popu-edge of the pharyngeal mesoderm-derived component
lations (Harada et al., 1999). Fgf10 null mice exhibit agen-of the heart. On the basis of these results, we propose
esis and dysgenesis of multiple organ systems yet havethat the embryonic heart is composed of cells derived
no reported heart defect, although detailed cardiac mor-from two myocardial precursor populations—one which
phology has not been described (Min et al., 1998; Sekinegives rise to the early heart tube and inflow region of
et al., 1999; Ohuchi et al., 2000). Overlap between thethe heart, and a second population of Fgf10-expressing
role of Fgf10 and other FGFs, such as Fgf8, which iscells in pharyngeal mesoderm which gives rise to the
expressed in a subset of precardiac mesodermal cellsOFT and possibly also the embryonic right ventricle.
including arterial pole precursor cells (Figure 2D), maySuch a model is consistent with evidence that the OFT
rescue arterial pole development in Fgf10 null mice.and right ventricle comprise distinct genetic modules
Future experiments will address the role of FGF signal-of the embryonic heart (Schwartz and Olson, 1999; Bru-
ing in arterial pole precursor cells and outflow tract mor-neau et al., 1999).
phogenesis.Our observations differ fundamentally from those of
neural crest cell migration into the OFT with respect to
Experimental Procedurestiming, distribution within the pharyngeal region, and
the resulting cell types within the heart. Neural crest The Mlc1v-nlacZ transgene contains 757 bp upstream of the tran-
cells are first observed in the mouse OFT at E9.5 (Jiang scriptional start site, the 5UTR and the first 33 codons of the mouse
Mlc1v/s myosin light chain gene upstream of nlacZ (Jerkovic et al.,et al., 2000; Epstein et al., 2000), whereas Mlc1v-nlacZ-
1997). The promoter contains a 34 bp deletion at150 relative to the24-expressing cells are observed in the arterial pole of
Mlc1v transcriptional start site. In line 24, integration has occurred atthe heart from E8. Cardiac neural crest cells migrate
a single locus containing two to three copies in a head-to-tail array.
predominantly through caudal branchial arches (see Transgene expression was monitored by -galactosidase activity
Waldo and Kirby, 1999), in contrast to the cell population using whole-mount and histological revelation as described by Kelly
expressing the Mlc1v-nlacZ-24 transgene and our DiI et al. (1995).
Inverse PCR was carried out using the Expand long template PCRlabeling results. Furthermore, neural crest cells marked
system (Roche) on Mlc1v-nlacZ-24 DNA ligated at low concentrationby the expression of a lacZ reporter gene activated by a
after SphI digestion. Products larger than a 1.2 kb interrepeat frag-Wnt1- or Pax3-regulated cre recombinase are excluded
ment were subcloned into a pGEM-T vector (Stratagene) prior to
from the mesodermal core of the branchial arches, thus DNA sequencing. PCR was used to confirm the authenticity of the
showing a reciprocal distribution to that of the Mlc1v- genomic-transgene junction. DNA sequence analysis was per-
formed using BLAST (Genbank, NCBI), and alignments were carriednlacZ-24 transgene (Jiang et al., 2000; Epstein et al.,
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out using DNA Strider Version 1.3 (CEA). PAC clones were obtained Hogan, B.L. (1999). Morphogenesis. Cell 96, 225–233.
from BACPAC Resources and mapped using PFG electrophoresis Jerkovic, R., Vitadello, M., Kelly, R., Buckingham, M., and Schiaffino,
and Southern blot hybridization as described by Hadchouel et al. S. (1997). Fibre type-specific and nerve-dependent regulation of
(2000). myosin light chain 1 slow promoter in regenerating muscle. J. Muscle
Embryo culture and DiI labeling were performed as described in Res. Cell Motil. 18, 369–373.
Franco et al. (2001); labeling at E8.25 was performed through the Jiang, X., Rowitch, D.H., Soriano, P., McMahon, A.P., and Sucov,
anterior intestinal portal, and at E9.5 through the visceral yolk sac. H.M. (2000). Fate of the mammalian cardiac neural crest. Develop-
Whole-mount ISH was carried out as described in Zammit et al. ment 127, 1607–1616.
(2000), followed by cryostat sectioning. Mouse Fgf10 and Fgf8 DNA
Jones, C.M., Lyons, K.M., and Hogan, B.L. (1991). Involvement offragments corresponding to the entire coding sequences were am-
Bone Morphogenetic Protein-4 (BMP-4) and Vgr-1 in morphogene-plified from E11.5 embryo cDNA. PCR products were subcloned
sis and neurogenesis in the mouse. Development 111, 531–542.into a pGEM-T vector and the sequence was verified. Full-length
Kelly, R., Alonso, S., Tajbakhsh, S., Cossu, G., and Buckingham, M.riboprobes were synthesized using SP6 RNA polymerase and BglII-
(1995). Myosin light chain 3F regulatory sequences confer regional-linearized templates. -cardiac actin and nlacZ riboprobes were as
ised cardiac and skeletal muscle expression in transgenic mice. J.described by Sassoon et al. (1988) and Kelly et al. (1995).
Cell Biol. 129, 383–396.
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